Perry Nicole D 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Perry Nicole D
Vice President - Finance
Transactions
- Exercise/Conversion
Common Stock
2021-06-11$3.20/sh+1,000$3,200→ 5,847 total - Sale
Common Stock
2021-06-11$61.55/sh−1,000$61,555→ 4,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-11−1,000→ 34,161 totalExercise: $3.20Exp: 2025-06-02→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2015 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.